AmeriCann, Inc. (OTCQB: ACAN) is a cannabis company that is engaged within the development and marketing of cultivation, processing, and product manufacturing facilities. The company’s subsidiary, AmeriCann Brands, Inc., intends on securing the necessary licenses to cultivate, produce, and process a wide range of products: flower, cannabis beverages, edibles, vape cartridges, concentrates, topicals, and more. The company utilizes greenhouse technology for its cultivation operations and is focused on GMP-Certified extraction and manufacturing infrastructure development. Shares of the cannabis company rallied 16.07%, during trading on Friday, June 7, 2019. Over the past month, AmeriCann has seen average daily volume of 44,312 shares. However, volume of 89,078 shares or dollar volume of $115,801, exchanged hands during trading on Friday.
Shares of AmeriCann gained on Friday, after the company provided an update on the construction of Building 1 of the Massachusetts Cannabis Center (MCC). The MCC project is a planned 52-acre parcel that is “permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure,” according to the company. Building 1 of the MCC is over 80% complete and will be a 30,000 sq. ft. facility used for cultivation and processing. Utilities have been connected and the greenhouse have been completed. The interior construction is almost complete, with epoxy flooring for its lab spaces. Furthermore, the MCC project is currently on track to receive its Temporary Certificate of Occupancy before the end of June and a final Certificate of Occupancy in August. Here is the full press release detailing of the construction update:
AmeriCann, Inc. Press Release:
DENVER, CO / ACCESSWIRE / June 6, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art cultivation, processing and product manufacturing facilities, provided a construction update on Building 1 of the Massachusetts Cannabis Center (MCC).
The construction of Building 1 of the MCC, a 30,000 square foot cultivation and processing facility, is more than 80 percent complete. All permanent utilities have been connected, the building’s exterior and greenhouse are finished, the interior construction is nearing completion and crews are installing the epoxy flooring for all laboratory spaces. The project is on schedule for a Temporary Certificate of Occupancy by the end of June and a final Certificate of Occupancy in August.
Massachusetts Cannabis Center Building 1
“The progress on construction has exceeded our expectations and we are nearing the final phase of construction on Building 1,” said Tim Keogh, CEO of AmeriCann. “We are full steam ahead on the designs for Building 2 which should be ready for construction by the end of this Summer.”
The MCC is being developed on a 52-acre parcel located in Southeastern Massachusetts. The MCC project is permitted for 987,000 sq. ft. of cannabis cultivation and processing infrastructure for the existing medical cannabis and the newly emerging adult-use cannabis marketplace.
AmeriCann has a 15-year Joint Venture Partnership with Bask, Inc., an existing Massachusetts licensed vertically integrated cannabis operator. AmeriCann will receive a Revenue Participation Fee of 15% of Gross Revenue on all products produced and sold from Building 1.
The Massachusetts cannabis market has some of the highest prices in the United States, with wholesale prices reaching $4,000 per pound and retail prices greater than $7,000 per pound. Building 1 is projected to produce 7,500 pounds annually of dry flower cannabis and over 400,000 units of infused products. AmeriCann projects a 1.5 year payback on its investment in Building 1.
AmeriCann’s Cannopy System, which will be used at the MCC, enables cannabis to be produced with a greatly reduced carbon footprint, making the final product cost less with higher margins. AmeriCann uses hybrid-greenhouse technology, which is superior to the current industry standard of growing cannabis in warehouse facilities under artificial lights. According to industry experts, by capturing natural sunlight, greenhouses use 25 percent fewer lights, and utility bills are up to 75 percent less than in typical warehouse cultivation facilities. Massachusetts has some of the highest energy costs in the nation, providing an even greater advantage to the MCC.
AmeriCann plans to replicate the brands, technology and innovations developed at its MCC project to new markets as a licensed multi-state operator (MSO).
As the first approved adult-use cannabis market on the Eastern U.S., Massachusetts has the potential to become the epicenter for cannabis innovation and research. According to the Cannabis Control Commission, Massachusetts recreational dispensaries have sold more than $139 million worth of cannabis products since recreational sales began in November 2018. Annual recreational retail sales are expected to total $1.3-1.6 billion in a few years, according to Marijuana Business Daily estimates.
AmeriCann (OTCQB: ACAN) is a cannabis company that is developing cultivation, processing and product manufacturing facilities.
AmeriCann uses greenhouse technology for cannabis cultivation and is designing GMP Certified cannabis extraction and product manufacturing infrastructure. Through a wholly-owned subsidiary, AmeriCann Brands, Inc., the Company intends to secure licenses to cultivate cannabis and produce cannabis infused products including beverages, edibles, topicals, vape cartridges and concentrates. AmeriCann Brands, Inc. plans to operate a Marijuana Product Manufacturing business at the Massachusetts Cannabis Center with over 40,000 square feet of state-of-the art extraction and product manufacturing infrastructure.
More information about the Company is available at: www.americann.co, or follow AmeriCann on social media:
About Massachusetts Cannabis Center
Massachusetts Cannabis Center (MCC), is a one million square foot sustainable greenhouse, processing and manufacturing facility in Freetown, Mass which is being developed by AmeriCann. The first phase of the facility is scheduled to open and be ready for cannabis cultivation, processing, and infused product production in the summer of 2019. Once fully developed, the MCC design calls for a research facility, a training center, corporate offices, a quality-assurance laboratory, and a facility for manufacturing cannabis-infused food, nutraceuticals and consumer packaged cannabis goods.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Registration Statement on Form S-1, which the Company recently filed with the SEC and which may be viewed at www.sec.gov.